drugset / Trial / NCT03178942

Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies

NCT03178942

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study to Evaluate the Therapeutic Equivalence of Permethrin Cream 5%in the Treatment of Scabies.

Timeline

Start
2017-06-01
Primary completion
2017-11-11
Completion
2017-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Permethrin Small molecule 5 %

Indications